• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

Recent Advances in the Study of Methyl 3-(3-aminophenyl)propanoate;hydrochloride (CAS: 103096-02-2)

Methyl 3-(3-aminophenyl)propanoate;hydrochloride (CAS: 103096-02-2) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, often utilized as an intermediate in the synthesis of more complex molecules, has recently garnered attention due to its potential applications in drug development and therapeutic interventions. The following research brief provides an overview of the latest findings related to this compound, highlighting its synthesis, biological activity, and potential applications in medicine.

Recent studies have focused on optimizing the synthesis of Methyl 3-(3-aminophenyl)propanoate;hydrochloride to improve yield and purity. A 2023 publication in the Journal of Medicinal Chemistry detailed a novel catalytic method that enhances the efficiency of the synthesis process, reducing byproduct formation and increasing overall yield. This advancement is particularly relevant for large-scale production, where consistency and cost-effectiveness are critical factors.

In addition to synthesis improvements, research has explored the biological activity of Methyl 3-(3-aminophenyl)propanoate;hydrochloride. Preliminary in vitro studies suggest that this compound may exhibit moderate inhibitory effects on certain enzymes involved in inflammatory pathways. A study published in Bioorganic & Medicinal Chemistry Letters in early 2024 reported that the compound demonstrated selective inhibition of cyclooxygenase-2 (COX-2), a key enzyme in the prostaglandin synthesis pathway. These findings suggest potential applications in the development of anti-inflammatory agents, though further in vivo studies are required to validate these effects.

Another area of interest is the compound's role as a building block for more complex pharmaceutical agents. Researchers have utilized Methyl 3-(3-aminophenyl)propanoate;hydrochloride in the synthesis of novel small-molecule inhibitors targeting protein-protein interactions. A recent study in ACS Chemical Biology highlighted its use in the development of a new class of kinase inhibitors, which show promise in oncology applications. The versatility of this compound as a synthetic intermediate underscores its importance in medicinal chemistry.

Despite these promising developments, challenges remain in fully understanding the pharmacokinetic and pharmacodynamic properties of Methyl 3-(3-aminophenyl)propanoate;hydrochloride. Current research is focused on addressing these gaps, with particular emphasis on its absorption, distribution, metabolism, and excretion (ADME) profiles. Collaborative efforts between academic and industrial researchers are expected to yield more comprehensive data in the near future.

In conclusion, Methyl 3-(3-aminophenyl)propanoate;hydrochloride (CAS: 103096-02-2) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Recent advancements in its synthesis, coupled with emerging evidence of its biological activity, position it as a valuable tool in drug discovery. Ongoing studies will likely expand its applications, particularly in the development of anti-inflammatory and anticancer therapies. Researchers are encouraged to explore its potential further, leveraging the latest synthetic and analytical techniques to unlock its full therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)